pharma news today obesity drugs glp-1 september 2025 Eli Lilly set to leapfrog Novo Nordisk in weight-loss drug race With China approval, Lilly and

Globally, CKD affects 8 to 16% of the population [2], and is very closely associated with adverse clinical outcomes and an increased risk of all-cause mortality [3]

Immunomodulatory therapeutic effects of curcumin on M1/M2 macrophage polarization in inflammatory diseases

Shima Hadidchi, MD, who can provide tailored treatment plans to suit your specific health goals

Tips to Maximize Your Semaglutide Weight Loss Results Importance of Monitoring Results Ongoing communication with your healthcare provider is essential for optimizing your treatment experience

I take it not to lose weight but because I was prediabetic, Im 70 years old, and Im predisposed to Alzheimers. Lipman takes his modest dose weekly, mainly for its neuroprotective and metabolic effects